Clinical Trials on Sjogren's Syndrome in France

Total 3361 results

University Hospital, Strasbourg, France

Completed

Efficacy of Tocilizumab in Primary Sjögren's Syndrome. (ETAP)

Primary Sjögren's Syndrome (pSS)

France
University Hospital, Brest

Recruiting

Diagnostic Suspicion of Primitive Syndrome Sjögren's : Brest Cohort (DIApSS)

Primary Sjögren's Syndrome (pSS)

France
Assistance Publique - Hôpitaux de Paris

Recruiting

New Clinical End-points in Patients With Primary Sjögren's Syndrome (NECESSITY)

Primary Sjögren's Syndrome (pSS)

France
Assistance Publique - Hôpitaux de Paris
Human Genome Sciences Inc.

Completed

Efficacy and Safety of Belimumab in Subjects With Primary Sjögren's Syndrome (BELISS)

Sjögren's Syndrome

France
Assistance Publique - Hôpitaux de Paris
Sanofi

Completed

Hydroxychloroquine Versus Placebo in Primary Sjögren's Syndrome (JOQUER)

Primary Sjögren's Syndrome

France
Assistance Publique - Hôpitaux de Paris
Societe Francaise de Rhumatologie

Recruiting

The ASSESS National Multi-center Prospective Cohort (ASSESS)

Primary Sjögren's Syndrome

France
Novartis Pharmaceuticals

Active, not recruiting

Biopsy Based Study to Understand Mechanism of Action of Ianalumab in Salivary Glands and Explore Relationships With Clinical Assessments.

Sjogren Syndrome

France
University Hospital, Limoges

Completed

Primary Sjögren Syndrome (NeuroSenSS)

Primary Sjögren's Syndrome

France
University Hospital, Strasbourg, France

Recruiting

Intravenous Immunoglobulins for the Treatment of Primary Sjögren's Syndrome Associated Painful Sensory Neuropathies (TINISS)

Primary Sjögren's Syndrome Painful Sensory Neuropathies

France
Centre Hospitalier Universitaire de Saint Etienne
Ministry of Health, France

Recruiting

Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity (I GET DRY)

Primary Sjögren's Syndrome

France
University Hospital, Brest

Unknown

Ultrasound Abnormalities of the Salivary Glands in Primary Sjögren's Syndrome According to the Duration of the Disease (MASAÏ)

Primary sjögren's Syndrome

France
UCB Celltech
PRA Health Sciences

Terminated

UCB Proof of Concept Study in Patients With Primary Sjögren's Syndrome

Primary Sjögren's Syndrome

France, Italy, Spain, Sweden, United Kingdom
MedImmune LLC
Amgen

Completed

A Phase 2a, Randomized, Placebo Controlled, Study to Evaluate the Safety and Efficacy of AMG 557/MEDI5872 in Primary Sjögren's Syndrome

Primary Sjögren's Syndrome

United States, Sweden, France, United Kingdom
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Completed

Efficacy and Safety of S95011 in Primary Sjögren's Syndrome Patients

Primary Sjögren's Syndrome

United States, France, United Kingdom, Australia, Germany, Hungary, Spain
University Hospital, Clermont-Ferrand

Unknown

Echo Systemic Sclerosis

Systemic Sclerosis | Gougerot Sjogren Syndrome | Sicca-Asthenia-Polyalgia Syndrome

France
Sanofi

Completed

Safety, Tolerability, Pharmacokinetics, and Therapeutic Efficacy of SAR441344 in Primary Sjögren's Syndrome (pSjS) (phaethuSA)

Sjogren's Syndrome | Sjögren's Syndrome

Belgium, Taiwan, Korea, Republic of, United States, Argentina, Canada, Chile, France, Germany, Hungary, Mexico, Spain
Amgen

Completed

A Study to Evaluate the Efficacy and Safety of VIB4920 in Participants With Sjögren's Syndrome (SS)

Sjögren's Syndrome

United States, France, Italy, Hungary, Poland, Argentina, India, Korea, Republic of, Mexico, Peru, Taiwan, United Kingdom
Novartis Pharmaceuticals

Recruiting

A Randomized, Double-blind 2-arm NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome. (NEPTUNUS-Ext)

Sjogrens Syndrome

United States, Spain, Austria, Belgium, Japan, Germany, Turkey, Hungary, Israel, Taiwan, Italy, France, Colombia, Argentina, Portugal, Australia, Slovakia, United Kingdom, Guatemala, Brazil, Czechia, Poland, Bulgaria, Canada, Lithuania, R...
University Hospital, Brest

Completed

Ultrasound Elastography of Salivary Glands (ELSA)

sjögren Disease

France
Bristol-Myers Squibb

Recruiting

A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome (POETYK SjS-1)

Sjögren's Syndrome

United States, Australia, Germany, Korea, Republic of, Austria, China, Spain, Japan, Puerto Rico, Poland, Canada, Hungary, Chile, Denmark, France, Italy, Mexico, Peru, Netherlands, Belgium, Brazil, Colombia, United Kingdom, Portugal, Sw... and more
Novartis Pharmaceuticals

Completed

Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS)

Primary Sjogren Syndrome

United States, Belgium, Italy, Austria, Israel, France, Germany, Hungary, Netherlands, United Kingdom, Japan, Portugal, Argentina, Spain, Taiwan, Russian Federation, Romania, Chile, Poland
Novartis Pharmaceuticals

Recruiting

Two-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome (NEPTUNUS-1)

Sjogren Syndrome

Brazil, Portugal, United States, Belgium, Spain, Germany, Korea, Republic of, Czechia, Mexico, France, Turkey, China, Guatemala, Austria, Chile, Poland, Singapore, Lithuania
Bristol-Myers Squibb

Completed

A Study to Assess the Efficacy and Safety of Abatacept in Adults With Active Primary Sjögrens Syndrome

Sjogrens Disease

United States, France, Italy, Sweden, Japan, Australia, Mexico, Argentina, Brazil, Korea, Republic of, Czechia, Puerto Rico, Germany
Novartis Pharmaceuticals

Recruiting

Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome (NEPTUNUS-2)

Sjogren Syndrome

Spain, Hungary, Germany, Canada, Greece, United Kingdom, Bulgaria, Japan, Colombia, United States, South Africa, Australia, China, Mexico, Israel, Lebanon, Taiwan, Argentina, Italy, France, Chile, Romania, India, Brazil, Poland, Slovakia, S...
Assistance Publique - Hôpitaux de Paris

Recruiting

Dental and Periodontal Status of Patients With Sjögren's Syndrome. (CB-SJO)

Sjögren Syndrome

France
University Hospital, Limoges

Completed

Neurotrophins Implications in Primary Sjögren Syndrome (Neuro-SGSp)

Primary Sjögren Syndrome

France
Bristol-Myers Squibb

Completed

Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis

Rheumatoid Arthritis | Systemic Lupus Erythematosus | Autoimmune Disorder | Primary Sjögren's Syndrome

United States, Argentina, Belgium, France, Germany, Mexico, Poland, Spain, Netherlands, United Kingdom
University Hospital, Brest

Completed

Tolerance and Efficiency of an Intrabuccal Biological Film to Enhance Oral Dryness Sensation: The "PREDELFI" Clinical Pilot Study (PREDELFI)

Xerostomia | Sicca Syndrome

France
University Hospital, Brest

Unknown

Inflammatory Myopathies in Primary Sjögren's Syndrome (AMISS)

Primary Sjögren Syndrome

France
University Hospital, Brest
Ministry of Health, France

Completed

Tolerance and Efficacy of Rituximab in Sjogren's Disease (TEARS)

Sjogren's Disease

France
University Hospital, Brest

Recruiting

B-dependant Rare AutoImmune diseaSES - Cohort of Patients With Suspected Diagnosis of Primitive Sjögren Syndrome (BRAISES-DiaPSS)

Sjogren's Syndrome

France
University Hospital, Bordeaux

Recruiting

Involvement of Immune Cells Derived From the Intestine in Sjogren's Syndrome (SINGOU)

Sjogren's Syndrome

France
University Hospital, Clermont-Ferrand

Recruiting

Ultrasound Characteristics of the Salivary Glands in Patients With Rheumatoid Arthritis (EchoPR)

Rheumatoid Arthritis | Sjogren's Syndrome | Sicca, Asthenia, Polyalgia Syndrome (SAPS)

France
Centre Hospitalier Universitaire de Nīmes

Recruiting

Descriptive Study of Variations in Serum Translocation Markers of the Intestinal Microbiota in Patients With Gougerot-Sjögren Syndrome According to Disease Activity (IMISS)

Sjogren's Syndrome

France
Centre Hospitalier Universitaire de Nice

Recruiting

Ro60 Expression in Macrophages in Sjogren's Disease (RoMioSS)

Sjogren's Syndrome

France
Unither Pharmaceuticals, France

Completed

A New Oral salIvary equivAlent Compared to Two moisturizinG Mouth sprAys in Patients With xeRostomiA: NIAGARA Study (NIAGARA)

Head and Neck Cancer | Xerostomia | Hyposalivation | Sjögren Syndrome

France
University Hospital, Montpellier

Recruiting

Quantification and Characterization of Circulating Epithelial and Endothelial Cells in Gougerot-Sjögren Syndrome, Compared to Systemic Sclerosis (CIRCEE)

Primary Gougerot-Sjögren Syndrome | Systemic Sclerosis, Diffuse

France
University Hospital, Montpellier

Completed

Vaccine Coverage and Primary Sjögren'Syndrome (VACGREN)

Primary Sjögren Syndrome

France
Université de Reims Champagne-Ardenne

Not yet recruiting

Olfactory and Taste Disturbances in Sjogren's Syndrome (TOG_SJOGREN)

Sjogren's Syndrome

France
University Hospital, Limoges

Completed

Evaluation of the Prevalence of Functional Digestive Disorders During Primary Sjögren Gougerot Syndrome (GASTRO-SGS)

Sjogren's Syndrome | Digestive System Abnormalities

France
Assistance Publique - Hôpitaux de Paris
CRAT; SNFMI; SFR

Recruiting

Pregnancy and Medically Assisted Conception in Rare Diseases (EGR2)

Rheumatoid Arthritis | Systemic Lupus Erythematosus | Vasculitis | Myositis | Psoriatic Arthritis | Antiphospholipid Syndrome | Sjogren Syndrome | Spondyloarthritis | Mastocytosis | Scleroderma | Various Autoimmune and/or Systemic and/or Rare Diseases

France
University Hospital, Montpellier

Completed

Patients With Co-occurrence of ANCA Vasculitis and Sjögren Syndrome

Sjogren's Syndrome | ANCA Associated Vasculitis

France
Assistance Publique - Hôpitaux de Paris
LFB BIOMEDICAMENTS

Recruiting

Medico-economic and Quality of Life Impact of Sjogren-associated Small Fiber Neuropathy (SFINESS-QoLEco)

Quality of Life | Small Fiber Neuropathy | Primary Sjögren Syndrome | Medico-economic Impact

France
University Hospital, Strasbourg, France

Recruiting

Assessment of Physician Consideration of ePRO's, From Patients With Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Systemic Lupus, on the Frequency of Therapeutic Adjustments (CAPTAIN)

Rheumatoid Arthritis | Systemic Lupus Erythematosus | Sjogren's Syndrome | Gout

France
Hoffmann-La Roche

Completed

A Study to Assess the Efficacy of RO5459072 in Participants With Primary Sjogren's Syndrome

Sjogren's Syndrome

United States, United Kingdom, Poland, Germany, Portugal, France
GlaxoSmithKline

Completed

Safety and Efficacy Study of Subcutaneous Belimumab and Intravenous Rituximab Co-administration in Subjects With Primary Sjogren's Syndrome

Sjogren's Syndrome

Spain, France, Germany, Netherlands, United Kingdom, Sweden, Argentina, Italy, Canada, Norway
Novartis Pharmaceuticals

Completed

Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjogren's Syndrome (TWINSS)

Sjögren Syndrome

United States, United Kingdom, Netherlands, Australia, Austria, Israel, France, Germany, Greece, Hungary, Italy, Korea, Republic of, Japan, Portugal, Russian Federation, Turkey, Canada, Colombia, Romania, Argentina, Chile, Brazil, S...
University Hospital, Brest

Recruiting

Polymyalgia Rheumatica Associated to Primary Sjogren Syndrome (PASS)

Polymyalgia Rheumatica | Sjogren's Syndrome

France
Janssen Research & Development, LLC

Completed

A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)

Sjogren's Syndrome

United States, Germany, Netherlands, Japan, Taiwan, Italy, France, Spain, Poland, Portugal
Novartis Pharmaceuticals

Active, not recruiting

Study of Safety and Tolerability of CFZ533 in Patients With Sjögren's Syndrome (TWINSS Extn)

Sjogren's Syndrome

United Kingdom, Netherlands, Australia, Austria, Israel, France, Germany, Greece, Hungary, Italy, United States, Korea, Republic of, Japan, Portugal, Russian Federation, Turkey, Colombia, Romania, Argentina, Chile, Brazil, Canada, S...

Clinical Trials on Sjogren's Syndrome in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations